Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00282776 · ClinicalTrials.gov registry record · Phase 3
Identification and Therapy of Postpartum Depression
A Phase 3 study of Depression, sponsored by University of Pittsburgh.
- Completed
- Registry status
- Phase 3
- Development phase
- 628
- Enrollment target
- 1
- Study location
NCT00282776: Completed Phase 3 study of Depression, sponsored by University of Pittsburgh.
NCT00282776 is a Phase 3 study of Depression that has completed, run by University of Pittsburgh. The registered enrollment target is 628 participants, below the 785-participant average among 679 other Depression trials with a reported enrollment target (20% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00282776, a Phase 3 study of Depression, has completed, sponsored by University of Pittsburgh.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 628 participants
- Enrollment target
- 1
- Study location
Study Summary
This study will evaluate the effectiveness of a telephone-based depression screening and care management program in treating depression in postpartum women.
Conditions Studied
Interventions
- BEHAVIORAL TAU
- BEHAVIORAL Care Management for Postpartum Depression
Study Locations (1)
Pennsylvania
- Women's Behavioral HealthCARE Program, Suite 410, 3501 Forbes Ave - Pittsburgh
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 628 participants |
| Start Date | 2006-08 |
| Est. Completion | 2012-03 |
| Phase | Phase 3 |
What the finished NCT00282776 record still lists
NCT00282776 is an interventional study that assigns participants to a tested intervention. The registered 628 participants enrollment target is mid-sized for trials with a published cap, below the 785-participant average among 679 other Depression trials with a reported enrollment target (20% lower).
The record links to 1 condition, with Depression appearing as the primary indexed condition, and to 2 interventions - of which TAU is the first listed.
NCT00282776 reports a single indexed study location in Pennsylvania.
Frequently Asked Questions
What is clinical trial NCT00282776 about?
NCT00282776 is a clinical study titled "Identification and Therapy of Postpartum Depression". This study will evaluate the effectiveness of a telephone-based depression screening and care management program in treating depression in postpartum women.
What is the current status of trial NCT00282776?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 628 participants. The study started on 2006-08. Estimated completion is 2012-03.
What conditions does trial NCT00282776 study?
This clinical trial studies the following conditions: Depression.
What interventions are being tested in trial NCT00282776?
The interventions under investigation include: TAU (BEHAVIORAL), Care Management for Postpartum Depression (BEHAVIORAL).
Who is sponsoring clinical trial NCT00282776?
This trial is sponsored by University of Pittsburgh, which has 1,238 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00282776 being conducted?
This trial has 1 study location across Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Depression
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT00282776's enrollment target sits among peer trials
628 66th of 679 higher than 613 of 679 other Depression trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Depression trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Behavioral Activation Delivered Via Home-based Telehealth to Improve Functioning in Cardiovascular Disease Patients Recently Discharged From Inpatient Care
RECRUITING · Phase 3
-
A Study of a Deuterated Psilocin Analog (CYB003) in Humans With Major Depressive Disorder
RECRUITING · Phase 3
-
A Study to Assess Change in Disease Activity and Adverse Events (AEs) With Cariprazine in the Treatment of Depressive Episodes in Pediatric Participants Participants (10 to 17 Years of Age) With Bipolar I Disorder.
RECRUITING · Phase 3
-
PCORI Comparative Effectiveness Study-Esketamine (Spravato) vs. Ketamine-Equivalence Study
RECRUITING · Phase 3
-
Creatine for Depressed Male and Female Methamphetamine Users
RECRUITING · Phase 3
-
E-Mindfulness Approaches for Living After Breast Cancer
RECRUITING · Phase 3
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04704921 · 630 participants · Phase 2
Pivotal 1 Study of ABBV-RGX-314 (Also Known as RGX-314) Gene Therapy Administered Via Subretinal Delivery One Time in Participants With nAMD
- NCT04707729 · 630 participants · NA
ROX Index for the Timing of Intubation in Nasal High Flow
- NCT05061550 · 630 participants · Phase 2
Neoadjuvant and Adjuvant Treatment in Resectable Non-small Cell Lung Cancer
- NCT05224440 · 630 participants · NA
National Sponsorship Program for Transitioning Service Members
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia